EWA
ABBV icon

Emergent Wealth Advisors’s AbbVie ABBV Stock Holding History

Emergent Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$792K Sell
3,161
-159
-5% -$34.2K 0.41% 47
2026
Q1 		$722K Sell
3,320
-55
-2% -$12.2K 0.43% 42
2025
Q4 		$771K Buy
3,375
+430
+15% +$98K 0.43% 50
2025
Q3 		$682K Buy
2,945
+291
+11% +$59.3K 0.4% 52
2025
Q2 		$493K Buy
2,654
+25
+1% +$4.65K 0.31% 60
2025
Q1 		$551K Sell
2,629
-107
-4% -$20.8K 0.4% 50
2024
Q4 		$486K Buy
2,736
+96
+4% +$17.6K 0.35% 55
2024
Q3 		$521K Buy
2,640
+134
+5% +$25K 0.39% 52
2024
Q2 		$437K Buy
2,506
+145
+6% +$24K 0.35% 55
2024
Q1 		$430K Buy
2,361
+4
+0.2% +$689 0.37% 53
2023
Q4 		$365K Buy
+2,357
New +$344K 0.34% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Emergent Wealth Advisors's ABBV Position: Q2 2026 in Review

Emergent Wealth Advisors reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $34.2K and leaving 3,161 shares worth $792K. The position accounts for 0.41% of the portfolio, ranked #47.

Emergent Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Emergent Wealth Advisors held 3,161 shares of AbbVie worth $792K as of Q2 2026.
  • Emergent Wealth Advisors sold 159 AbbVie shares in Q2 2026, an estimated $34.2K.
  • AbbVie made up 0.41% of Emergent Wealth Advisors's portfolio in Q2 2026, its #47 holding.
  • Emergent Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Emergent Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.